NDM-1 News and Guide

You can be aware of the latest NDM-1 news on a daily basis. Every day there are up to 10-15 related news stories. We sort them, weed out the duplicates and then create two things. A free daily newsletter, and our Twitter feed.

NDM-1 and the other resistance agents often found with it such as carbapenemases and ESBL infections are causing worldwide concern as they slowly erode the impact of key antibiotics. We gather news from medical sources, conventional media and our own research to enable you to be aware of this unfolding problem. The information we gather will be of interest to infection specialists, health care workers, patient advocates and patients. Sign up to our email updates to keep informed.

Sign up for our free NDM-1, carbapenemases and ESBL newsletter!

See below for the latest NDM-1 related news
Go here for for KPC, CRE and Carbapenem related news.
A patient friendly guide is also available here
Go here for ESBL related news

NDM-1 Introduction

Latest NDM-1 News

NDM-1 News – Medical Journals

We monitor medical journals for the latest research on issues surrounding NDM-1. We pay particular attention to items about transmission, treatment, key drugs and infection control. With over 200 relevant journal articles being released every year, our service can help you see the latest research headlines at a glance.

NDM-1 News – Twitter

We discover cutting edge analysis via the Twitter accounts of leading infection control specialists, medical journalists and national and international agencies. These unique voices are at the heart of the science surrounding NDM-1 and the discussions about key trends and best practice.

NDM-1 – Mainstream media

Newspapers all over the world carry NDM-1 related news. We monitor this using news alert software and add key stories to our news feed as well as removing the many duplicates of the same story that sometimes appear. The media shape popular perceptions of the extent and impact of NDM-1. Our NDM-1 news service helps you discover, in 2 minutes a day, the important stories that you might want to explore further.

The newsletter and Twitter feed we offer are unique. We believe they will be helpful to infection control specialists, general nursing staff, patient advocates, medical equipment manufacturers and those working on NDM-1 related drug projects. They are both free. Sponsors for the newsletter are welcome – you can find more information by emailing dave(at)tahilla.com

3 thoughts on “NDM-1 News and Guide

  1. Barguellil Farouk

    I would like to signal you an new abstract :

    Emergence of NDM-1 in association with OXA-48 in a Klebsiella pneumoniae from Tunisia
    Adam Ben Nasr1,2, Dominique Decré3,4, Fabrice Compain3, Nathalie Genel3, Farouk Barguellil2,5 and Guillaume Arlet3,4⇑
    + Author Affiliations

    1Laboratoire de biologie médicale, hôpital Habib Thameur, Tunis
    2Département de Microbiologie, Faculté de Pharmacie de Monastir, Université de Monastir
    3Université Pierre et Marie Curie, Faculté de Médecine, Département de Bactériologie
    4Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Est Parisiens, Département de Bactériologie
    5Service de Microbiologie, hôpital militaire de Tunis

    The carbapenemase New Delhi metallo-β-lactamase-1 (NDM-1) initially identified in Escherichia coli and Klebsiella pneumoniae in 2008 in a Swedish patient who was repatriated to Sweden from India (1) is spreading rapidly worldwide except in central and south America.…


    Corresponding Author, Professor Guillaume Arlet, Département de Bactériologie, Faculté de Médecine, « site saint-antoine », 27 rue Chaligny, 75012 Paris, France

  2. Barguellil Farouk

    When I make a search on your site there is no results with any key words like Tunisia , Algeria, …..

Comments are closed.